UNITED STATES SECURITIES AND EXCHANGE
COMMISSION

Washington, D.C. 20549








Form 10-Q/A

(Amendment No. 1)



| | x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
| | - | ---------------------------------------------------------------------------------------



| |  | For the quarterly period ended March 31, 2012
| |  | ---------------------------------------------



OR



| |  ̈ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
| | - | ----------------------------------------------------------------------------------------



| |  | For the transition period from            to
| |  | --------------------------------------------



Commission file number 001-35050



ENDOCYTE, INC.

(Exact name of Registrant as specified
in its charter)














|Delaware                        | 35-1969-140           
|------------------------------- | ----------------------
|(State or other jurisdiction of | (I.R.S. Employer      
|incorporation or organization)  | Identification Number)



3000 Kent Avenue, Suite A1-100

West Lafayette, IN 47906

(Address of Registrant’s principal
executive offices)



Registrant’s telephone number,
including area code: (765) 463-7175



Securities registered pursuant to Section
12(b) of the Act:



Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),
and (2) has been subject to such filing requirements for the past 90 days. YesxNo
 ̈



Indicate
by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive
Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such
shorter period that the registrant was required to submit and post such files). YesxNo
 ̈



Indicate by check mark
whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.
See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company”
in Rule 12b-2 of the Exchange Act. (Check one):



|Large accelerated filer ̈ | Accelerated filer ̈                             | Non-accelerated filerx | Smaller reporting company ̈
|------------------------ | ---------------------------------------------- | ---------------------- | --------------------------
|                         | (Do not check if a  smaller reporting company)



Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ̈No x



Number of shares of
the registrant’s Common Stock, $0.001 par value, outstanding on May 1, 2012: 35,837,144






















EXPLANATORY NOTE



This Amendment on Form 10-Q/A is being
filed for the sole purpose of refiling Exhibits 31.1 and 31.2 which inadvertantly omitted a portion of paragraph 4 of
such certifications.













SIGNATURES



Pursuant to the requirements of the Securities
Exchange Act of 1934, as amended, the Registrant has duly caused this amended report to be signed on its behalf by the undersigned,
thereunto duly authorized.



|                        | ENDOCYTE, INC.
|----------------------- | --------------
|                        |               
|Date: September 7, 2012 | By:           
|                        |               
|                        |               
|                        |               
|                        |               
|Date: September 7, 2012 | By:           
|                        |               
|                        |               
|                        |               
|                        |               
|Date: September 7, 2012 | By:           
|                        |               
|                        |               
|                        |